Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Operating Leases (2020 - 2024)

Pharma-Bio Serv's Operating Leases history spans 5 years, with the latest figure at $28834.0 for Q4 2024.

  • For Q4 2024, Operating Leases fell 85.14% year-over-year to $28834.0; the TTM value through Oct 2024 reached $28834.0, down 85.14%, while the annual FY2024 figure was $28834.0, 85.14% down from the prior year.
  • Operating Leases reached $28834.0 in Q4 2024 per PBSV's latest filing, down from $71362.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $729389.0 in Q1 2020 to a low of $28834.0 in Q4 2024.
  • Average Operating Leases over 5 years is $393144.6, with a median of $400460.0 recorded in 2022.
  • Peak YoY movement for Operating Leases: dropped 18.42% in 2021, then plummeted 85.14% in 2024.
  • A 5-year view of Operating Leases shows it stood at $629979.0 in 2020, then fell by 22.64% to $487364.0 in 2021, then decreased by 28.9% to $346509.0 in 2022, then crashed by 44.0% to $194035.0 in 2023, then tumbled by 85.14% to $28834.0 in 2024.
  • Per Business Quant, the three most recent readings for PBSV's Operating Leases are $28834.0 (Q4 2024), $71362.0 (Q3 2024), and $113044.0 (Q2 2024).